Genentech (RHHBY) to Acquire Seragon Pharma in ~$1.73B Deal

July 2, 2014 8:00 AM EDT Send to a Friend
Genentech, a member of the Roche Group (OTCBB: RHHBY), announced it has entered into a definitive agreement to acquire Seragon ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login